Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 5/20 | 0.56 |
| ▸ | CCR1 | P32246 | 2/20 | 0.53 |
| ▸ | CCR8 | P51685 | 2/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.49 |
| ▸ | MAPT | P10636 | 6/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.48 |
| ▸ | NR4A2 | P43354 | 2/20 | 0.43 |
| ▸ | HSP90AA1 | P07900 | 4/20 | 0.40 |
| ▸ | MEN1 | O00255 | 4/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.40 |
| ▸ | HTT | P42858 | 3/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.40 |
| ▸ | MMP14 | P50281 | 3/20 | 0.40 |
| ▸ | TP53 | P04637 | 2/20 | 0.40 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.40 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.40 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1615610 | 0.98 | LMNA (0.54) | LMNACCR1CCR8L3MBTL1ALDH1A1 | |
| SCHEMBL2950262 | 0.98 | LMNA (0.54) | LMNACCR1CCR8L3MBTL1ALDH1A1 | |
| Hydrochloric Acid SCHEMBL2528246 | 0.98 | LMNA (0.54) | LMNACCR1CCR8L3MBTL1ALDH1A1 | |
| SCHEMBL3298981 | 0.95 | LMNA (0.51) | LMNACCR1CCR8L3MBTL1ALDH1A1 | |
| SCHEMBL28884057 | 0.85 | LMNA (0.52) | LMNACCR1CCR8L3MBTL1ALDH1A1 | |
| 1-Naphthoquinoline SCHEMBL4219087 | 0.80 | ALDH1A1 (0.64) | LMNACCR1CCR8L3MBTL1ALDH1A1 | |
| SCHEMBL15673966 | 0.78 | ALDH1A1 (0.56) | LMNAL3MBTL1ALDH1A1MAPTKDM4E | |
| SCHEMBL10923942 | 0.78 | LMNA (0.53) | LMNACCR1CCR8L3MBTL1ALDH1A1 | |
| SCHEMBL29463567 | 0.77 | CCR1 (0.62) | LMNACCR1CCR8L3MBTL1ALDH1A1 | |
| SCHEMBL5455738 | 0.77 | CCR1 (0.62) | LMNACCR1CCR8L3MBTL1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108232205-B | Non-noble metal catalyst and process for producing the same | 现代自动车株式会社 | 2022-10-11 | — | — | CN | disclosed |
| CN-113651836-A | Organic compound and organic electroluminescent device containing same | 清华大学 | 2021-11-16 | — | — | CN | disclosed |
| CN-107586296-A | The preparation method and applications of the phenanthroline and its iron complex of the substitution of 2,9 diaryl | 南开大学 | 2018-01-16 | — | — | CN | disclosed |
| CN-102354221-B | Actuator | 精工爱普生株式会社 | 2016-06-22 | — | — | CN | disclosed |
| EP-2609640-B1 | PHOTOACTIVE COMPOSITION AND ELECTRONIC DEVICE MADE WITH THE COMPOSITION | DU PONT (US) | 2015-11-25 | — | — | EP | disclosed |
| CN-102695777-B | Electroactive composition and the electron device obtained by said composition | E.I. Nemours DuPont (US) | 2015-11-25 | — | — | CN | disclosed |
| EP-2376595-B1 | PHOTOACTIVE COMPOSITION AND ELECTRONIC DEVICE MADE WITH THE COMPOSITION | DU PONT (US) | 2015-01-21 | — | — | EP | disclosed |
| CN-102239230-B | Photoactive composition and electronic device made with the composition | DU PONT | 2014-06-25 | — | — | CN | disclosed |
| US-8617720-B2 | Electroactive composition and electronic device made with the composition | E I DU PONT DE NEMOURS AND COMPANY (US) | 2013-12-31 | — | — | US | disclosed |
| EP-2669967-A1 | Electronic device including phenanthroline derivative | E. I. du Pont de Nemours and Company (US) | 2013-12-04 | — | — | EP | disclosed |
| CN-1890769-B | Electric storage element and method for manufacturing electric storage element | EAMEX CORP | 2010-10-06 | — | — | CN | disclosed |
| US-20100207108-A1 | ELECTRONIC DEVICE INCLUDING PHENANTHROLINE DERIVATIVE | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-08-19 | — | — | US | disclosed |
| WO-2010075411-A2 | PHOTOACTIVE COMPOSITION AND ELECTRONIC DEVICE MADE WITH THE COMPOSITION | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-07-01 | — | — | WO | disclosed |
| WO-2010075379-A2 | ELECTRONIC DEVICE INCLUDING PHENANTHROLINE DERIVATIVE | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-07-01 | — | — | WO | disclosed |
| WO-2010068865-A2 | PHOTOACTIVE COMPOSITION AND ELECTRONIC DEVICE MADE WITH THE COMPOSITION | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-06-17 | — | — | WO | disclosed |
| CN-1890769-A | Electric storage element and method for manufacturing electric storage element | EAMEX CORP (JP) | 2007-01-03 | — | — | CN | disclosed |
| EP-1696446-A1 | CAPACITOR AND METHOD FOR MANUFACTURING SAME | Eamex Corporation (JP) | 2006-08-30 | — | — | EP | disclosed |
| US-20060134442-A1 | Method for electroless plating | EAMEX CORPORATION (JP) | 2006-06-22 | — | — | US | disclosed |
| EP-0339973-A1 | Substituted 1,10-phenanthrolines | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1989-11-02 | — | — | EP | disclosed |
| WO-1989010366-A1 | SUBSTITUTED 1,10-PHENANTHROLINES | EASTMAN KODAK COMPANY (US) | 1989-11-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100207108-A1 | ELECTRONIC DEVICE INCLUDING PHENANTHROLINE DERIVATIVE | PAH, AHR, TYR | LMNA 2873/4885CCR1 3200/4885CCR8 3719/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.